3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Breast Neoplasms
22
Neoplasms
16
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
8
Neoplasm Metastasis
7
Lung Neoplasms
7
Lymphoma
6
Hematologic Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Multiple Myeloma
5
Glioblastoma
5
Stomach Neoplasms
4
Leukemia
4
Fatigue
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Fallopian Tube Neoplasms
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Interventions
aldesleukin
42
Sunitinib
39
Cyclophosphamide
30
Nivolumab
27
Everolimus
27
pembrolizumab
26
Interferon-alpha
25
Bevacizumab
22
Sorafenib
21
Interleukin-2
20
fludarabine phosphate
19
Filgrastim
18
Ipilimumab
17
Radiotherapy
16
Axitinib
16
Peripheral Blood Stem Cell Transplantation
15
Gemcitabine
15
cabozantinib
14
fludarabine
11
Radiosurgery
11
Doxorubicin
11
Carboplatin
11
temsirolimus
10
Etoposide
9
Chemotherapy, Adjuvant
9
sargramostim
8
belzutifan
8
atezolizumab
8
Fluorouracil
8
pazopanib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Kidney Neoplasms
×
Palliative Care
×
Clear all
NCT03652298
2026-03-13
NeuroPrevPTSD
Centre Oscar Lambret
Phase 2
Terminated
19 enrolled